19395184

Source:http://linkedlifedata.com/resource/pubmed/id/19395184

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011065, umls-concept:C0035647, umls-concept:C0039601, umls-concept:C0279025, umls-concept:C0376358, umls-concept:C1272706, umls-concept:C2004454
pubmed:issue	1
pubmed:dateCreated	2009-8-21
pubmed:abstractText	To assess whether the risk of death is associated with the time to testosterone recovery (TTR) after radiotherapy (RT) and hormonal therapy (HT) for prostate cancer (PCa).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Flutamide, http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Testosterone
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1879-355X
pubmed:author	pubmed-author:ChenMing-HuiMH, pubmed-author:D'AmicoAnthony VAV, pubmed-author:KantoffPhilip WPW, pubmed-author:LoffredoMarianM, pubmed-author:RenshawAndrew AAA
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	75
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	10-5
pubmed:meshHeading	pubmed-meshheading:19395184-Age Factors, pubmed-meshheading:19395184-Aged, pubmed-meshheading:19395184-Aged, 80 and over, pubmed-meshheading:19395184-Androgen Antagonists, pubmed-meshheading:19395184-Antineoplastic Agents, Hormonal, pubmed-meshheading:19395184-Cause of Death, pubmed-meshheading:19395184-Comorbidity, pubmed-meshheading:19395184-Confidence Intervals, pubmed-meshheading:19395184-Flutamide, pubmed-meshheading:19395184-Follow-Up Studies, pubmed-meshheading:19395184-Gonadotropin-Releasing Hormone, pubmed-meshheading:19395184-Humans, pubmed-meshheading:19395184-Male, pubmed-meshheading:19395184-Middle Aged, pubmed-meshheading:19395184-Neoplasm Recurrence, Local, pubmed-meshheading:19395184-Prostate-Specific Antigen, pubmed-meshheading:19395184-Prostatic Neoplasms, pubmed-meshheading:19395184-Radiotherapy, Conformal, pubmed-meshheading:19395184-Regression Analysis, pubmed-meshheading:19395184-Risk Assessment, pubmed-meshheading:19395184-Testosterone, pubmed-meshheading:19395184-Time Factors
pubmed:year	2009
pubmed:articleTitle	Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
pubmed:affiliation	Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. adamico@partners.org
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Multicenter Study